Angiotensin II-converting enzyme inhibitors (ACEIs) and selective angiotensin II receptor
antagonists (ARAIIs) are widely used antihypertensive agents. Their use has generated …

Purpose of Review HEARTS in the Americas is the regional adaptation of Global Hearts, the
World Health Organization initiative for cardiovascular disease (CVD) prevention and …

HEARTS in the Americas, the regional adaptation of the WHO Global HEARTS Initiative, is
being implemented in 24 countries and over 2000 primary healthcare facilities across the …

Cardiovascular diseases (CVD), principally ischemic heart disease (IHD) and stroke, are the
leading causes of death (18. 6 million deaths annually) and disability (393 million disability …

Objective. To quantify the association between the prevalence of population hypertension
control and ischemic heart disease (IHD) and stroke mortality in 36 countries of the Americas …

Hypertension fluctuates significantly every year, especially in Jembrana Regency. Long-
term consumption of the drug may result in complications. This study aims to analyze the …

Continuous monitoring plays a crucial role in diagnosing hypertension, characterized by the
increase in Arterial Blood Pressure (ABP). The gold-standard method for obtaining ABP …

Abstract Endocrine disrupting Chemicals (EDCs) are substances that interfere with
hormones by several mechanisms including receptor activation or antagonism, changes in …

Tahajjud, a type of sunnah worship for Muslims, involves standard rules and complex
movements that contribute to cardiovascular health and blood pressure regulation. Aims and …

Background Timing drug administration to endogenous circadian rhythms may enhance
treatment efficacy. In the Chronotype sub-study of the Treatment in Morning versus Evening …